Indicators of Lung Shunt Fraction Determined by Technetium-99 m Macroaggregated Albumin in Patients with Hepatocellular Carcinoma. 2017

Joseph Ralph Kallini, and Ahmed Gabr, and Ryan Hickey, and Laura Kulik, and Kush Desai, and Yihe Yang, and Vanessa L Gates, and Ahsun Riaz, and Riad Salem, and Robert J Lewandowski
Section of Interventional Radiology, Department of Radiology, Northwestern Memorial Hospital, Robert H. Lurie Comprehensive Cancer Center, 676 N. St. Clair Street, Suite 800, Chicago, IL, USA.

OBJECTIVE To determine the correlation of pre-procedural and imaging characteristics with lung shunt fraction (LSF) measured by technetium-99 m macroaggregated albumin (99mTc-MAA) scan in patients with hepatocellular carcinoma. METHODS A retrospective study was conducted of 428 subjects with hepatocellular carcinoma from 2004 to 2011 assessed for lung shunting by 99mTc-MAA scan. Baseline characteristics included age, gender, ethnicity, tumor burden, maximum dimension, number of lesions, presence of extrahepatic metastases, macrovascular (hepatic and portal vein) invasion, ascites on imaging, laboratory values, and alpha-fetoprotein (AFP). Univariate and multivariate logistic regression analysis was performed. Receiver operating characteristic curves were used to obtain sensitivity (SN), specificity (SP), and positive likelihood ratios (LR+) of characteristics for low LSF (LSF <10%) and high LSF (LSF >20%). RESULTS Statistically significant (p < 0.05) independent indicators of low LSF included bilirubin <1.45 mg/dL (SN = 49.5%, SP = 69.1%, LR+ = 1.60), maximum tumor size <7.15 cm (SN = 66.0%, SP = 75.9%, LR+ = 2.74), AFP ≤200 ng/mL (SN = 64.6%, SP = 65.0%, LR+ = 1.85), and absent macrovascular invasion (SN = 73.9%, SP = 64.9%, LR+ = 2.11). Independent indicators of high LSF included albumin <2.65 g/dL (SN = 64.3%, SP = 64.1%, LR+ = 1.79) and macrovascular invasion (SN = 74.4%, SP = 67.4%, LR+ = 2.28). A combined risk factor model was constructed. If there is no macrovascular invasion: [Formula: see text]. With macrovascular invasion, [Formula: see text] (R 2 = 0.257). Since these factors all have LR+ between 2 and 5, they only reflect slight increase in LSF predictivity. CONCLUSIONS Serum AFP, albumin, bilirubin, and portal/hepatic vein invasion on cross-sectional imaging are statistically significant but weak clinical indicators of LSF, as shown by low SN, SP, and LR+ for clinically relevant cutoff LSF values. Thus, these factors cannot be relied upon in clinical practice.

UI MeSH Term Description Entries
D008113 Liver Neoplasms Tumors or cancer of the LIVER. Cancer of Liver,Hepatic Cancer,Liver Cancer,Cancer of the Liver,Cancer, Hepatocellular,Hepatic Neoplasms,Hepatocellular Cancer,Neoplasms, Hepatic,Neoplasms, Liver,Cancer, Hepatic,Cancer, Liver,Cancers, Hepatic,Cancers, Hepatocellular,Cancers, Liver,Hepatic Cancers,Hepatic Neoplasm,Hepatocellular Cancers,Liver Cancers,Liver Neoplasm,Neoplasm, Hepatic,Neoplasm, Liver
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011169 Portal Vein A short thick vein formed by union of the superior mesenteric vein and the splenic vein. Portal Veins,Vein, Portal,Veins, Portal
D011879 Radiotherapy Dosage The total amount of radiation absorbed by tissues as a result of radiotherapy. Dosage, Radiotherapy,Dosages, Radiotherapy,Radiotherapy Dosages
D011880 Radiotherapy Planning, Computer-Assisted Computer-assisted mathematical calculations of beam angles, intensities of radiation, and duration of irradiation in radiotherapy. Computer-Assisted Radiotherapy Planning,Dosimetry Calculations, Computer-Assisted,Planning, Computer-Assisted Radiotherapy,Calculation, Computer-Assisted Dosimetry,Calculations, Computer-Assisted Dosimetry,Computer Assisted Radiotherapy Planning,Computer-Assisted Dosimetry Calculation,Computer-Assisted Dosimetry Calculations,Dosimetry Calculation, Computer-Assisted,Dosimetry Calculations, Computer Assisted,Planning, Computer Assisted Radiotherapy,Radiotherapy Planning, Computer Assisted
D004621 Embolization, Therapeutic A method of hemostasis utilizing various agents such as Gelfoam, silastic, metal, glass, or plastic pellets, autologous clot, fat, and muscle as emboli. It has been used in the treatment of spinal cord and INTRACRANIAL ARTERIOVENOUS MALFORMATIONS, renal arteriovenous fistulas, gastrointestinal bleeding, epistaxis, hypersplenism, certain highly vascular tumors, traumatic rupture of blood vessels, and control of operative hemorrhage. Embolotherapy,Therapeutic Embolization,Embolizations, Therapeutic,Embolotherapies,Therapeutic Embolizations
D005260 Female Females
D006528 Carcinoma, Hepatocellular A primary malignant neoplasm of epithelial liver cells. It ranges from a well-differentiated tumor with EPITHELIAL CELLS indistinguishable from normal HEPATOCYTES to a poorly differentiated neoplasm. The cells may be uniform or markedly pleomorphic, or form GIANT CELLS. Several classification schemes have been suggested. Hepatocellular Carcinoma,Hepatoma,Liver Cancer, Adult,Liver Cell Carcinoma,Liver Cell Carcinoma, Adult,Adult Liver Cancer,Adult Liver Cancers,Cancer, Adult Liver,Cancers, Adult Liver,Carcinoma, Liver Cell,Carcinomas, Hepatocellular,Carcinomas, Liver Cell,Cell Carcinoma, Liver,Cell Carcinomas, Liver,Hepatocellular Carcinomas,Hepatomas,Liver Cancers, Adult,Liver Cell Carcinomas

Related Publications

Joseph Ralph Kallini, and Ahmed Gabr, and Ryan Hickey, and Laura Kulik, and Kush Desai, and Yihe Yang, and Vanessa L Gates, and Ahsun Riaz, and Riad Salem, and Robert J Lewandowski
March 1967, The International journal of applied radiation and isotopes,
Joseph Ralph Kallini, and Ahmed Gabr, and Ryan Hickey, and Laura Kulik, and Kush Desai, and Yihe Yang, and Vanessa L Gates, and Ahsun Riaz, and Riad Salem, and Robert J Lewandowski
January 1994, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Joseph Ralph Kallini, and Ahmed Gabr, and Ryan Hickey, and Laura Kulik, and Kush Desai, and Yihe Yang, and Vanessa L Gates, and Ahsun Riaz, and Riad Salem, and Robert J Lewandowski
September 1974, Radiology,
Joseph Ralph Kallini, and Ahmed Gabr, and Ryan Hickey, and Laura Kulik, and Kush Desai, and Yihe Yang, and Vanessa L Gates, and Ahsun Riaz, and Riad Salem, and Robert J Lewandowski
November 1998, The American journal of cardiology,
Joseph Ralph Kallini, and Ahmed Gabr, and Ryan Hickey, and Laura Kulik, and Kush Desai, and Yihe Yang, and Vanessa L Gates, and Ahsun Riaz, and Riad Salem, and Robert J Lewandowski
December 2023, Scientific reports,
Joseph Ralph Kallini, and Ahmed Gabr, and Ryan Hickey, and Laura Kulik, and Kush Desai, and Yihe Yang, and Vanessa L Gates, and Ahsun Riaz, and Riad Salem, and Robert J Lewandowski
January 1971, Polski przeglad radiologii i medycyny nuklearnej,
Joseph Ralph Kallini, and Ahmed Gabr, and Ryan Hickey, and Laura Kulik, and Kush Desai, and Yihe Yang, and Vanessa L Gates, and Ahsun Riaz, and Riad Salem, and Robert J Lewandowski
September 1987, Clinical nuclear medicine,
Joseph Ralph Kallini, and Ahmed Gabr, and Ryan Hickey, and Laura Kulik, and Kush Desai, and Yihe Yang, and Vanessa L Gates, and Ahsun Riaz, and Riad Salem, and Robert J Lewandowski
August 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
Joseph Ralph Kallini, and Ahmed Gabr, and Ryan Hickey, and Laura Kulik, and Kush Desai, and Yihe Yang, and Vanessa L Gates, and Ahsun Riaz, and Riad Salem, and Robert J Lewandowski
January 1988, Digestive diseases and sciences,
Joseph Ralph Kallini, and Ahmed Gabr, and Ryan Hickey, and Laura Kulik, and Kush Desai, and Yihe Yang, and Vanessa L Gates, and Ahsun Riaz, and Riad Salem, and Robert J Lewandowski
August 2022, Scientific reports,
Copied contents to your clipboard!